Ray Sumita — SEC insider filings
SEC reporting owner CIK 1579629. 16 insider filings on record with FilingPulse; latest filed 2026-10-14.
Transaction summary — filings shown
Covers all 16 filings on record, filed 2021-01-22 to 2026-10-14. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 4 legs across 2 filings — 10,673 shares, $317,352 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 20.
- Largest priced transaction: sale of 6,442 shares @ $30.35 ($195,515) in Cue Biopharma, Inc., filed 2026-08-17.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Cue Biopharma, Inc. (CUE) | Chief Legal Compliance Officer | 3 | — | 4 legs · 10,673 sh · $317,352 | 4 |
| Biomea Fusion, Inc. (BMEA) | Director | 7 | — | — | 7 |
| Calithera Biosciences, Inc. (CALA) | See Remarks | 4 | — | — | 6 |
| Instil Bio, Inc. (TIL) | Chief Legal and Admin Officer | 1 | — | — | 2 |
| Vaxxinity, Inc. (VAXX) | Chief Legal, Comp & Admin Off | 1 | — | — | 1 |
Insider filings — Ray Sumita
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-10-14 | 4 | Cue Biopharma, Inc. (CUE) | Sale (S): 1,844 @ $28.05 | EDGAR |
| 2026-08-17 | 4 | Cue Biopharma, Inc. (CUE) | Option exercise (M): 18,196 @ $0 · Sale (S): 2,383 @ $29.37 · Sale (S): 6,442 @ $30.35 · Sale (S): 4 @ $31.13 · Option exercise (M): 18,196 (derivative) @ $0 | EDGAR |
| 2026-07-10 | 4 | Cue Biopharma, Inc. (CUE) | Grant/award (A): 54,589 @ $0 · Grant/award (A): 54,589 (derivative) @ $0 | EDGAR |
| 2026-06-12 | 4 | Biomea Fusion, Inc. (BMEA) | Grant/award (A): 196,299 (derivative) @ $0 | EDGAR |
| 2025-06-13 | 4 | Biomea Fusion, Inc. (BMEA) | Grant/award (A): 91,970 (derivative) @ $0 | EDGAR |
| 2024-06-13 | 4 | Biomea Fusion, Inc. (BMEA) | Grant/award (A): 51,025 (derivative) @ $0 | EDGAR |
| 2024-04-29 | 4 | Vaxxinity, Inc. (VAXX) | Grant/award (A): 425,000 (derivative) @ $0 | EDGAR |
| 2023-06-16 | 4 | Biomea Fusion, Inc. (BMEA) | Grant/award (A): 6,989 (derivative) @ $0 | EDGAR |
| 2023-01-20 | 4 | Instil Bio, Inc. (TIL) | Grant/award (A): 415,000 (derivative) @ $0 · Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2022-06-24 | 4 | Biomea Fusion, Inc. (BMEA) | Grant/award (A): 23,867 (derivative) @ $0 | EDGAR |
| 2022-03-07 | 4 | Biomea Fusion, Inc. (BMEA) | Grant/award (A): 21,461 (derivative) @ $0 | EDGAR |
| 2022-01-27 | 4 | Calithera Biosciences, Inc. (CALA) | Grant/award (A): 165,000 (derivative) @ $0 | EDGAR |
| 2021-11-09 | 4 | Calithera Biosciences, Inc. (CALA) | Grant/award (A): 12,000 @ $0 | EDGAR |
| 2021-10-29 | 4 | Calithera Biosciences, Inc. (CALA) | Grant/award (A): 36,000 @ $0 | EDGAR |
| 2021-06-21 | 4 | Biomea Fusion, Inc. (BMEA) | Grant/award (A): 17,724 (derivative) @ $0 | EDGAR |
| 2021-01-22 | 4 | Calithera Biosciences, Inc. (CALA) | Grant/award (A): 30,000 @ $0 · Grant/award (A): 12,000 @ $0 · Grant/award (A): 125,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2021-01-21 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1579629 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs